Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2864-2876
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2864
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2864
Variables | Baseline | SVR12 | ||
r | P value | r | P value | |
Age | 0.050 | 0.662 | 0.107 | 0.346 |
BMI | -0.007 | 0.951 | 0.057 | 0.617 |
HCV RNA | 0.043 | 0.702 | 0.025 | 0.827 |
Hb | 0.143 | 0.205 | 0.131 | 0.246 |
WBC | 0.047 | 0.677 | -0.152 | 0.178 |
Platelets count | -0.118 | 0.297 | -0.299 | 0.007b |
ALT | -0.090 | 0.425 | -0.129 | 0.256 |
AST | -0.227 | 0.043a | 0.006 | 0.961 |
ALP | -0.024 | 0.831 | 0.106 | 0.350 |
Albumin | 0.016 | 0.888 | 0.070 | 0.535 |
Total bilirubin | 0.268 | 0.016a | 0.111 | 0.326 |
Creatinine | 0.158 | 0.162 | 0.088 | 0.439 |
INR | 0.063 | 0.582 | 0.220 | 0.049a |
AFP | -0.098 | 0.388 | 0.026 | 0.822 |
- Citation: Saleh SA, Salama MM, Alhusseini MM, Mohamed GA. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World J Gastroenterol 2020; 26(21): 2864-2876
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2864.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2864